Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal health products in powder form, as well as in oral and injectable solution forms. The company was founded in 1940 and is based in Cairo, Egypt. Memphis Pharmaceuticals & Chemical Industries is a subsidiary of HoldiPharma.
Metrics to compare | MPCI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMPCIPeersSector | |
---|---|---|---|---|
P/E Ratio | 4.6x | 9.6x | −0.5x | |
PEG Ratio | −0.08 | 0.02 | 0.00 | |
Price/Book | 2.8x | 1.8x | 2.6x | |
Price / LTM Sales | 1.4x | 1.2x | 3.1x | |
Upside (Analyst Target) | - | 4.6% | 45.7% | |
Fair Value Upside | Unlock | 14.6% | 5.7% | Unlock |